KDR and colorectal adenocarcinoma: In conclusion, our results indicate that multiparametric CEUS with VEGFR2-targeted MB allows for monitoring functional and molecular therapy effects of regorafenib on the investigated experimental colorectal adenocarcinomas in rats.